The STAR Report is a syndicated market research offering from The Brooks Group and Mark Krueger & Associates, Inc., allowing you to benchmark your company’s advocacy relations efforts against your competitors.

The STAR Report will help you understand emerging policy and advocacy trends, enabling you to quickly and efficiently develop, commercialize, differentiate, and secure reimbursement for your products.

 

Benefits of STAR

STAR Report survey findings will identify:

  • Which companies are most respected by patient and professional groups
  • Short and long-term goals within specific advocacy communities
  • How advocacy groups address access and reimbursement
  • Which pharma company public policy activities are the most effective
  • Which companies provide value-added programs that are most appreciated by advocacy groups
  • Which companies are evaluated as the best overall

 

Why STAR?

Healthcare policy is changing dramatically, and the impact of the changes will be felt across many areas, including reimbursement and patient advocacy. The STAR Report puts patient advocacy relations in the forefront and will help pharmaceutical and biotech executives identify how their companies are impacted by the external environment. STAR research will help them become better prepared to take advantage of—and respond quickly to—the opportunities and threats impacting their business strategy. 

 

Research Methodology

STAR market research is comprehensive and includes both qualitative and quantitative information. It also interprets the current trends in healthcare policy. Each edition of the STAR Report includes: 

  • Primary research—online, quantitative surveys
  • Primary research—in-depth, qualitative interviews
  • Secondary research—literature search and interpretation

 

Delivery Methods and Frequency

  • Comprehensive handbooks delivered each spring and fall to your company
  • Web access to chapters
  • Timely research updates 
  • Two onsite consultative visits with a Brooks Group/MK&A consultant

Sample Research Agendas

Spring:

  • Management Summary
  • Leading Pharmaceutical/Biotech Companies in Patient Advocacy Relations
  • Longitudinal Assessment: 2010 vs. 2011 Comparison of Leading Companies in Advocacy Relations
  • Leading Pharmaceutical/Biotech Companies in Professional Group Relations
  • Leading Pharmaceutical/Biotech Companies in Patient Advocacy Relations by Therapeutic Area
  • Access and Reimbursement Activities
  • Perspectives on Healthcare Reform: Key Healthcare Initiatives

Fall:

  • Management Summary
  • Leading Pharmaceutical/Biotech Companies in Public Policy (patient and professional)
  • Longitudinal Assessment: 2010 vs 2011 Comparison of Leading Companies in Public Policy
  • Model Corporate Advocacy Relations Programs
  • Leading Pharmaceutical/Biotech Companies in Public Policy by Therapeutic Area
  • Perspectives on Healthcare Reform: Perspectives on Innovation
  • Forming a Successful Advisory Board

 

The Brooks Group
Karen Ernst, MBA

Send E-mail
301 Lacey Street, 1st Floor
West Chester, PA 19382

www.thebrooksgrouponline.com

Mark Krueger & Associates, Inc.
Amber Spierer, MPH

521 Fifth Avenue, 27th Floor
New York, NY 10175

www.kruegerandassociates.com